BioMed Nexus Daily Updates brings you the latest breakthroughs, trends, and news in Biotech, MedTech, and Pharma—delivered fresh every day. From cutting-edge innovations to industry shifts, our concise recaps keep you ahead in a fast-moving field. Join 20,000+ subscribers.
The pharmaceutical industry’s marketing playbook is about to get a major rewrite. The FDA has announced an aggressive campaign against misleading drug advertisements, signaling the
Microbiome subsidiary faces workforce reduction following ulcerative colitis study setback, highlighting development risks in emerging therapeutic area Vedanta Biosciences, PureTech Health’s microbiome-focused subsidiary, announced workforce
Sector evolution marked by breakthrough approvals, billion-dollar transactions, and emerging health challenges Recent global biotech developments showcase the sector’s dynamic nature, with breakthrough drug approvals,
Concord Biotech Plummets: Shares crashed 27% by Feb 14, capping a brutal week after a failed trial sank hopes—smallcap biotech’s reeling. Economic Times calls it
Latent Labs Unveils AI: On Feb 13, Latent Labs launched an AI platform targeting proteins and RNA for drug discovery, boasting 30% faster hit rates.
Pharma Bribery Risk Looms: Trump’s Feb 12 executive order paused enforcement of the Foreign Corrupt Practices Act, stirring fears of a bribery surge in global
